Multiple Assemblies exist for SMTL entry 4hhy
Crystal structure of PARP catalytic domain in complex with novel inhibitors; X-RAY DIFFRACTION 2.36 Å

	SMTL ID 4hhy.1 Ligands (9aR)-1-[(1-{2-fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzoyl}piperidin-4-yl)carbonyl]-1,2,3,8,9,9a-hexahydro-7H-benzo[de][1,7]naphthyridin-7-one Polypeptides Poly [ADP-ribose] polymerase 1 Oligo-state monomer
	SMTL ID 4hhy.2 Ligands (9aR)-1-[(1-{2-fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzoyl}piperidin-4-yl)carbonyl]-1,2,3,8,9,9a-hexahydro-7H-benzo[de][1,7]naphthyridin-7-one Polypeptides Poly [ADP-ribose] polymerase 1 Oligo-state monomer
	SMTL ID 4hhy.3 Ligands (9aR)-1-[(1-{2-fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzoyl}piperidin-4-yl)carbonyl]-1,2,3,8,9,9a-hexahydro-7H-benzo[de][1,7]naphthyridin-7-one; SULFATE ION; DI(HYDROXYETHYL)ETHER Polypeptides Poly [ADP-ribose] polymerase 1 Oligo-state monomer
	SMTL ID 4hhy.4 Ligands (9aR)-1-[(1-{2-fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzoyl}piperidin-4-yl)carbonyl]-1,2,3,8,9,9a-hexahydro-7H-benzo[de][1,7]naphthyridin-7-one; SULFATE ION Polypeptides Poly [ADP-ribose] polymerase 1 Oligo-state monomer